Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
An inborn error of valine metabolism. The prevalence is unknown. Only one symptomatic patient (with anemia, failure to thrive, dilated cardiomyopathy and plasma carnitine deficiency) has been described so far, but several series of patients have been identified through newborn screening programs relying on detection of increased C(4)-carnitine levels by tandem mass spectrometry. The disorder is caused by mutations in the ACAD8 gene (11q25).
Features include: Decreased circulating carnitine concentration, Low red blood cell count (anemia), Low muscle tone (hypotonia), and Enlarged and weakened heart (dilated cardiomyopathy).
Organ System | Phenotype Count | Example Features |
|---|---|---|
Blood and immune system | 1 | Low red blood cell count (anemia) |
ACAD8 encodes acyl-CoA dehydrogenase family member 8 (415 aa). Isobutyryl-CoA dehydrogenase which catalyzes the conversion of 2-methylpropanoyl-CoA to (2E)-2-methylpropenoyl-CoA in the valine catabolic pathway. Highest expression in Thyroid (53.1 TPM) and Brain Cerebellum (35.4 TPM).
Isobutyryl-CoA dehydrogenase deficiency is caused by mutations in the ACAD8 gene on chromosome 11.
The ACAD8 protein participates in isobutyryl-CoA + FAD = methacrylyl-CoA + FADH2 pathway.
ACAD8 is classified as a druggable target (Enzyme category) with score 0.0.
42 pathogenic variants reported in ACAD8 in ClinVar, including hotspot variants LRG_448p1:p.Ala320Thr (2-star review) and LRG_448p1:p.Gly377Ser (2-star review).
Genetic testing for ACAD8 is available. Testing is considered confirmatory for diagnosis.
Estimated prevalence: Unknown (Unknown prevalence).
No clinical trials have been registered for isobutyryl-CoA dehydrogenase deficiency.
8 publications have been identified in PubMed for isobutyryl-CoA dehydrogenase deficiency. Research spans Basic Science / Preclinical (38%), Review / Meta-Analysis (25%), and Epidemiology / Natural History (25%).
Wang JY (2026). [PMID: 42115600](https://pubmed.ncbi.nlm.nih.gov/42115600/). *Nat Commun*. [Basic Science / Preclinical]
Santacruz Reyes MD (2026). [PMID: 41606743](https://pubmed.ncbi.nlm.nih.gov/41606743/). *Orphanet J Rare Dis*. [Review / Meta-Analysis]
Tao Y (2025). [PMID: 40330009](https://pubmed.ncbi.nlm.nih.gov/40330009/). *Front Genet*. [Case Report / Case Series]
Hong S (2025). [PMID: 40618281](https://pubmed.ncbi.nlm.nih.gov/40618281/). *Hum Mol Genet*. [Basic Science / Preclinical]
Huang S (2025). [PMID: 41440809](https://pubmed.ncbi.nlm.nih.gov/41440809/). *Int J Neonatal Screen*. [Review / Meta-Analysis]
Data assembled from 8 of 12 sources · Last updated Sep 19, 2026, 3:02 PM UTC
Online Mendelian Inheritance in Man
European rare disease database
Genetic and Rare Diseases Info Center
1 |
Low muscle tone (hypotonia) |
Heart and blood vessels | 1 | Enlarged and weakened heart (dilated cardiomyopathy) |
Significance |
|---|
Review Stars |
|---|
Hotspot |
|---|
LRG_448p1:p.Ala320Thr | Pathogenic/Likely pathogenic | 2 stars | Yes |
LRG_448p1:p.Gly377Ser | Pathogenic/Likely pathogenic | 2 stars | Yes |
Zhang Z (2024). [PMID: 34647701](https://pubmed.ncbi.nlm.nih.gov/34647701/). *Minerva Pediatr (Torino)*. [Epidemiology / Natural History]
Green CR (2024). [PMID: 39551140](https://pubmed.ncbi.nlm.nih.gov/39551140/). *J Biol Chem*. [Basic Science / Preclinical]